ArticleEClinicalMedicine2026

Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study.

Jian-Jian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.